Although renal biopsy remains the diagnostic gold standard, its invasiveness, potential complications, and sampling variability limit its routine clinical application ( These challenges have catalyzed the search for innovative strategies for early detection, prognosis, and precision treatment that can augment the current standard of care defined by international guidelines such as KDIGO ( SGLT2 inhibitors and GLP-1RAs has reshaped the therapeutic landscape, demonstrating robust and glycemia-independent renoprotective benefits (Tomita et al., 2020)
The present paper will hopefully offer that crucial link in the decision-making process that most clinicians seek
While clinical studies generally show similar absorption across all sites, some individuals find that injecting in the thigh or back of the arm reduces nausea compared to the stomach
However, these events were generally mild and rarely led to treatment discontinuation
PlexusDx compounded GLP-1 protocols similarly carry transparent per-month pricing ($129/mo to $349/mo) bundled into a single subscription with no consultation fees simplifying budget planning for patients without GLP-1 coverage
The use of short acting GLP-1RA drugs has shown to improve glycemic control and promote insulin sectretion (53)